Neutrophilic Panniculitides
Ganesh B. Maniam MD, MBA, Anne Coakley MD, Giang Huong Nguyen MD, DPhil, Afsaneh Alavi MD, Mark D.P. Davis MD
{"title":"Neutrophilic Panniculitides","authors":"Ganesh B. Maniam MD, MBA, Anne Coakley MD, Giang Huong Nguyen MD, DPhil, Afsaneh Alavi MD, Mark D.P. Davis MD","doi":"10.1016/j.det.2023.08.005","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2023-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S073386352300075X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
中性盘尼西林
中性粒细胞泛肽是一种异质性的炎性疾病,包括许多不同的实体。本文就该病的流行病学、发病机制、临床病理特点、诊断和治疗作一综述。患者往往寻求护理,由于全身累及,但多肽的可变表现可以提出诊断的挑战。大多数中性粒细胞疾病的治疗方式最多是轶事,明显缺乏对药物反应的标准化。迫切需要进行更大规模的多机构合作,以解决这些具有挑战性但罕见的疾病的未满足需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。